Daniël J. Vis
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 8
- Oncology 12
- Cancer Immunotherapy and Biomarkers 4
- PARP inhibition in cancer therapy 4
- Co-authors
- Age K. Smilde (12 shared papers)Johan A. Westerhuis (11 shared papers)Huub C. J. Hoefsloot (9 shared papers)John van Duynhoven (3 shared papers)Ewoud J. J. van Velzen (2 shared papers)Ferdi A. van Dorsten (2 shared papers)Suzanne Smit (1 shared paper)Lodewyk F.A. Wessels (19 shared papers)
- Journals
- Nature Medicine (4 papers)Metabolomics (3 papers)Scientific Reports (3 papers)Nature Communications (3 papers)Cancer Cell (2 papers)
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
Daniël J. Vis
52 papers receiving 6.4k citations
Daniël J. Vis's Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 1.0k
- Oncology 1.6k
- Molecular Biology 3.3k
- Biophysics 258
- Computational Theory and Mathematics 644
Countries citing papers authored by Daniël J. Vis
This map shows the geographic impact of Daniël J. Vis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël J. Vis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël J. Vis more than expected).
Fields of papers citing papers by Daniël J. Vis
This network shows the impact of papers produced by Daniël J. Vis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël J. Vis. The network helps show where Daniël J. Vis may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniël J. Vis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Landscape of Pharmacogenomic Interactions in Cancer Hit paper breakdown → | 2016 | 1451 |
| 2 | Assessment of PLSDA cross validation Hit paper breakdown → | 2008 | 1221 |
| 3 | Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients Hit paper breakdown → | 2019 | 593 |
| 4 | Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial Hit paper breakdown → | 2020 | 325 |
| 5 | Effective drug combinations in breast, colon and pancreatic cancer cells Hit paper breakdown → | 2022 | 320 |
| 6 | 2018 | 301 | |
| 7 | 2019 | 243 | |
| 8 | 2015 | 224 | |
| 9 | 2005 | 167 | |
| 10 | 2016 | 138 | |
| 11 | 2007 | 137 | |
| 12 | 2011 | 132 | |
| 13 | 2015 | 120 | |
| 14 | 2022 | 97 | |
| 15 | 2009 | 97 | |
| 16 | 2018 | 95 | |
| 17 | 2009 | 88 | |
| 18 | 2016 | 70 | |
| 19 | 2020 | 65 | |
| 20 | 2016 | 61 |
About Daniël J. Vis
Daniël J. Vis is a scholar working on Cancer Research, Oncology, Molecular Biology, Computational Theory and Mathematics and Surgery, having authored 53 papers that have together received 6.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Bioinformatics and Genomic Networks (9 papers), Cancer Genomics and Diagnostics (8 papers), Metabolomics and Mass Spectrometry Studies (8 papers), Computational Drug Discovery Methods (6 papers), Prostate Cancer Treatment and Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.6k citations), Molecular Biology (3.3k citations), Biophysics (258 citations) and Computational Theory and Mathematics (644 citations). Daniël J. Vis has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Age K. Smilde, Johan A. Westerhuis, Huub C. J. Hoefsloot, John van Duynhoven, Ewoud J. J. van Velzen, Ferdi A. van Dorsten, Suzanne Smit, Lodewyk F.A. Wessels, J. van der Greef and André Boorsma. Their work appears in journals such as Nature Medicine, Metabolomics, Scientific Reports, Nature Communications and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.